美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

施贵宝

57.27

+0.67001.18%

盘后：57.00-0.2700-0.47%19:59 EDT

成交量：957.59万

成交额：5.49亿

市值：1,165.88亿

市盈率：16.04

高：57.82

开：57.03

低：56.79

收：56.60

52周最高：62.89

52周最低：42.52

股本：20.36亿

流通股本：20.32亿

量比：0.56

换手率：0.47%

股息：2.50

股息率：4.37%

每股收益(TTM):3.57

每股收益(LYR):3.46

净资产收益率：38.73%

总资产收益率：10.69%

市净率：5.81

市盈率(LYR):16.55

数据加载中...

总览公司新闻资讯公告

异动解读｜施贵宝盘中上涨3.13%，多重利好叠加行业回暖共振

健康快讯：放射性植入物可改善脑癌手术后的治疗效果

百时美施贵宝：Iza-Bren在重度经治患者群体中展现可控安全性，未观察到新的安全信号

施贵宝Izalontamab Brengitecan在TNBC和ESCC中展现显著的OS与PFS改善

异动解读｜施贵宝盘中下跌3.1%，报55.2美元

FDA优先审评施贵宝Camzyos补充新药申请，用于治疗青少年症状性梗阻性肥厚型心肌病

施贵宝免疫疗法组合获批用于治疗既往未治疗的III/IV期经典霍奇金淋巴瘤成人与青少年患者（12岁及以上）

施贵宝宣布欧狄沃®联合AVD疗法获欧盟扩大标签，获批用于一线治疗晚期经典型霍奇金淋巴瘤

Incyte的血液癌症联合用药方案可降低疾病进展风险，但副作用发生率较高

Replimune的皮肤癌药物在美国获批迎来第三次机会

百时美施贵宝的药物可延缓难治性多发性骨髓瘤患者的病情进展

施贵宝：Mezikd显著提升二/三线及高危疾病患者无进展生存期

施贵宝：Mezikd安全性特征与已知的Mezigdomide及联合疗法特征一致

施贵宝宣布：新药Celmod Mezigdomide在复发或难治性多发性骨髓瘤治疗中，较标准疗法降低疾病进展或死亡风险超50%

施贵宝：Mezikd在复发或难治性多发性骨髓瘤中，较标准疗法降低疾病进展/死亡风险超50%

施贵宝：Mezikd展现更高总体缓解率及完全缓解或更佳疗效

JW首席执行官表示，中国制药行业未受北京方面对敏感技术交易审查的影响

施贵宝将于2026年ASCO®大会公布新数据，展示其肿瘤学产品组合与下一代管线的创新实力与广度

数据简报-制药行业加大力度布局人工智能，寄望于大幅削减成本并缩短研发周期

制药巨头集体拥抱AI智能体：百时美施贵宝(BMY.US)向3万员工推广Claude

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BMY/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMY\",,,,,undefined,":{"symbol":"BMY","market":"US","secType":"STK","nameCN":"施贵宝","latestPrice":57.27,"timestamp":1780689600000,"preClose":56.6,"halted":0,"volume":9575913,"hourTrading":{"tag":"盘后","latestPrice":57,"preClose":57.27,"latestTime":"19:59 EDT","volume":542708,"amount":31080538.4805,"timestamp":1780703971432,"change":-0.27,"changeRate":-0.004715,"amplitude":0.006111},"delay":0,"changeRate":0.011837455830388723,"floatShares":2031646263,"shares":2035753027,"eps":3.569767,"marketStatus":"未开盘","change":0.67,"latestTime":"06-05 16:00:00 EDT","open":57.03,"high":57.815,"low":56.79,"amount":549382673.25603,"amplitude":0.01811,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.569767,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1780905600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":-18475200000,"exchange":"NYSE","adjPreClose":56.6,"dividendRate":0.043683,"preHourTrading":{"tag":"盘前","latestPrice":57.0125,"preClose":56.6,"latestTime":"09:28 EDT","volume":3595,"amount":204257.72615,"timestamp":1780666092143,"change":0.4125,"changeRate":0.007288,"amplitude":0.01835},"postHourTrading":{"tag":"盘后","latestPrice":57,"preClose":57.27,"latestTime":"19:59 EDT","volume":542708,"amount":31080538.4805,"timestamp":1780703971432,"change":-0.27,"changeRate":-0.004715,"amplitude":0.006111},"volumeRatio":0.5561763162717647,"impliedVol":0.2608,"impliedVolPercentile":0.0916},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMY\",,,,,undefined,":{"symbol":"BMY","floatShares":2031646263,"roa":"10.69%","roe":"38.73%","lyrEps":3.46,"volumeRatio":0.5561763162717647,"shares":2035753027,"dividePrice":2.5017,"high":57.815,"amplitude":0.01811,"preClose":56.6,"low":56.79,"week52Low":42.52,"pbRate":"5.81","psRate":"2.40","week52High":62.8864,"institutionHeld":0.7128,"latestPrice":57.27,"eps":3.569767,"divideRate":0.043683,"volume":9575913,"delay":0,"ttmEps":3.569767,"open":57.03,"prevYearClose":53.94,"prevWeekClose":57.18,"prevMonthClose":57.18,"prevQuarterClose":60.65,"fiveDayClose":57.18,"twentyDayClose":56.25,"sixtyDayClose":59.98,"dividendPayoutRate":0.7151007066521378,"dividendFrequency":"Q","dividendGrowthYears":4,"dividendGrowthRate":0.03333333333333337,"fiveYearAvgDividendRate":0.037305679384724975},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMY\",params:#limit:5,,,undefined,":[{"date":"2026-07-30","symbol":"BMY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/06","expectedEps":1.61,"defaultRemindTime":1785398400000,"name":null,"time":"盘前","dateTimestamp":1785384000000,"actualEps":null},{"market":"US","date":"2026-04-30","symbol":"BMY","fiscalQuarterEnding":"2026/03","expectedEps":1.44,"name":null,"time":"盘前","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"pre","actualEps":1.58},{"date":"2026-04-02","symbol":"BMY","amount":0.63,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-02","defaultRemindTime":1775136600000,"name":"施贵宝","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-01","payableDate":"2026-04-02","currency":"USD","dateTimestamp":1775102400000,"payDate":"2026-05-01"},{"market":"US","date":"2026-02-05","symbol":"BMY","fiscalQuarterEnding":"2025/12","expectedEps":1.65,"name":null,"time":"盘前","type":"earning","dateTimestamp":1770267600000,"reportTimeType":"pre","actualEps":1.67},{"date":"2026-01-02","symbol":"BMY","amount":0.63,"announcedDate":"2025-12-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-02","defaultRemindTime":1767364200000,"name":"施贵宝","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-02","payableDate":"2026-01-02","currency":"USD","dateTimestamp":1767330000000,"payDate":"2026-02-02"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMY\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-29","recordDate":"2016-07-01","paymentDate":"2016-08-01","value":0.38,"currency":"USD"},{"executeDate":"2016-10-05","recordDate":"2016-10-07","paymentDate":"2016-11-01","value":0.38,"currency":"USD"},{"executeDate":"2017-04-05","recordDate":"2017-04-07","paymentDate":"2017-05-01","value":0.39,"currency":"USD"},{"executeDate":"2017-07-05","recordDate":"2017-07-07","paymentDate":"2017-08-01","value":0.39,"currency":"USD"},{"executeDate":"2017-10-05","recordDate":"2017-10-06","paymentDate":"2017-11-01","value":0.39,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1563,"buy":0.1875,"hold":0.5938,"sell":0.0625,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.5938,"analysts":32,"updateTime":1780027200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BMY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BMY","date":"2026-06-05","current":16.043064,"percent":0.470732,"low":-30.323822,"twenty":-15.710126,"median":16.30513,"eighty":22.400619,"high":27.240851,"avg":6.593632,"sd":18.675991,"marketCap":115581232580},"quantilePoints":[{"date":"2021-06-11","current":-24.177472,"twenty":13.076111,"median":38.321748,"eighty":64.853776,"marketCap":150359698461},{"date":"2021-06-18","current":-23.865111,"twenty":12.918943,"median":37.341182,"eighty":64.853776,"marketCap":148417124394},{"date":"2021-06-25","current":-23.962051,"twenty":12.713253,"median":37.032625,"eighty":64.853776,"marketCap":149019992208},{"date":"2021-07-02","current":-24.037448,"twenty":12.656819,"median":36.735495,"eighty":64.853776,"marketCap":149488889397},{"date":"2021-07-09","current":-24.112846,"twenty":12.542371,"median":36.569788,"eighty":64.853776,"marketCap":149957786585},{"date":"2021-07-16","current":-24.163111,"twenty":12.276028,"median":36.398367,"eighty":64.853776,"marketCap":150270384711},{"date":"2021-07-23","current":-24.536508,"twenty":12.058207,"median":36.20409,"eighty":64.853776,"marketCap":152592542216},{"date":"2021-07-30","current":-29.693807,"twenty":11.96591,"median":36.009813,"eighty":61.057,"marketCap":150814846842},{"date":"2021-08-06","current":-29.803185,"twenty":-14.753585,"median":35.906961,"eighty":60.876911,"marketCap":151370375230},{"date":"2021-08-13","current":-29.536304,"twenty":-14.987324,"median":35.781252,"eighty":60.876911,"marketCap":150014885963},{"date":"2021-08-20","current":-30.275696,"twenty":-15.059273,"median":34.627419,"eighty":60.876911,"marketCap":153770257867},{"date":"2021-08-27","current":-29.138169,"twenty":-15.115938,"median":34.17561,"eighty":60.876911,"marketCap":147992762629},{"date":"2021-09-03","current":-28.705034,"twenty":-15.248154,"median":33.35279,"eighty":60.876911,"marketCap":145792870212},{"date":"2021-09-10","current":-27.62001,"twenty":-15.348311,"median":32.979745,"eighty":60.876911,"marketCap":140282028600},{"date":"2021-09-17","current":-26.823741,"twenty":-15.441509,"median":32.518541,"eighty":60.876911,"marketCap":136237781934},{"date":"2021-09-24","current":-26.35123,"twenty":-15.542928,"median":32.364263,"eighty":60.876911,"marketCap":133837899297},{"date":"2021-10-01","current":-26.036223,"twenty":-15.613954,"median":32.061419,"eighty":60.876911,"marketCap":132237977539},{"date":"2021-10-08","current":-25.051826,"twenty":-15.777999,"median":31.581441,"eighty":60.876911,"marketCap":127238222044},{"date":"2021-10-15","current":-25.533087,"twenty":-16.234944,"median":30.750116,"eighty":60.876911,"marketCap":129682546953},{"date":"2021-10-22","current":-25.200579,"twenty":-16.36727,"median":30.429194,"eighty":60.876911,"marketCap":127993740652},{"date":"2021-10-29","current":-23.982843,"twenty":-22.664495,"median":30.34167,"eighty":60.876911,"marketCap":129627264204},{"date":"2021-11-05","current":-24.414041,"twenty":-23.13914,"median":30.156897,"eighty":60.876911,"marketCap":131957891385},{"date":"2021-11-12","current":-24.405828,"twenty":-23.227463,"median":30.035336,"eighty":60.876911,"marketCap":131913498487},{"date":"2021-11-19","current":-23.748763,"twenty":-23.330148,"median":29.933224,"eighty":60.876911,"marketCap":128362066591},{"date":"2021-11-26","current":-23.214899,"twenty":-23.393674,"median":29.797076,"eighty":60.876911,"marketCap":125476528175},{"date":"2021-12-03","current":-23.128659,"twenty":-23.393674,"median":29.729002,"eighty":60.876911,"marketCap":125010402739},{"date":"2021-12-10","current":-23.145086,"twenty":-23.461298,"median":29.636615,"eighty":60.876911,"marketCap":125099188536},{"date":"2021-12-17","current":-25.280544,"twenty":-23.568548,"median":27.951968,"eighty":60.876911,"marketCap":136641342198},{"date":"2021-12-23","current":-25.48177,"twenty":-23.634806,"median":27.65765,"eighty":60.876911,"marketCap":137728968216},{"date":"2021-12-31","current":-25.60497,"twenty":-23.766579,"median":27.039995,"eighty":60.876911,"marketCap":138394861697},{"date":"2022-01-07","current":-25.802089,"twenty":-23.903887,"median":26.592299,"eighty":60.865513,"marketCap":139460291266},{"date":"2022-01-14","current":-26.664486,"twenty":-23.969949,"median":26.503175,"eighty":60.865513,"marketCap":144121545629},{"date":"2022-01-21","current":-26.093661,"twenty":-24.000827,"median":26.434777,"eighty":60.865513,"marketCap":141036239169},{"date":"2022-01-28","current":-26.656272,"twenty":-24.081403,"median":26.28969,"eighty":60.865513,"marketCap":144077152730},{"date":"2022-02-04","current":20.625497,"twenty":-24.122181,"median":26.107856,"eighty":60.865513,"marketCap":144254724325},{"date":"2022-02-11","current":20.843465,"twenty":-24.122181,"median":25.804687,"eighty":60.865513,"marketCap":145779193401},{"date":"2022-02-18","current":21.052274,"twenty":-24.122181,"median":24.80247,"eighty":60.865513,"marketCap":147239600991},{"date":"2022-02-25","current":21.441842,"twenty":-24.122181,"median":24.575651,"eighty":60.865513,"marketCap":149964242016},{"date":"2022-03-04","current":21.616368,"twenty":-24.122181,"median":24.306674,"eighty":60.865513,"marketCap":151184881195},{"date":"2022-03-11","current":21.463658,"twenty":-24.122181,"median":23.979644,"eighty":60.865513,"marketCap":150116821913},{"date":"2022-03-18","current":22.133715,"twenty":-24.122181,"median":23.933202,"eighty":60.865513,"marketCap":154803204476},{"date":"2022-03-25","current":22.26692,"twenty":-24.122181,"median":23.737758,"eighty":60.865513,"marketCap":155734841105},{"date":"2022-04-01","current":22.431005,"twenty":-24.122181,"median":23.392104,"eighty":60.865513,"marketCap":156882450469},{"date":"2022-04-08","current":23.631255,"twenty":-24.122181,"median":23.0415,"eighty":60.865513,"marketCap":165277000447},{"date":"2022-04-14","current":23.552252,"twenty":-24.122181,"median":23.0415,"eighty":60.865513,"marketCap":164724447790},{"date":"2022-04-22","current":23.017457,"twenty":-24.122181,"median":22.955165,"eighty":60.865513,"marketCap":160984091344},{"date":"2022-04-29","current":25.636645,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":160254667678},{"date":"2022-05-06","current":26.113479,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":163235357657},{"date":"2022-05-13","current":25.817161,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":161383071741},{"date":"2022-05-20","current":25.949993,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":162213406807},{"date":"2022-05-27","current":25.932963,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":162106953593},{"date":"2022-06-03","current":25.602585,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":160041761251},{"date":"2022-06-10","current":25.575338,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":159871436109},{"date":"2022-06-17","current":25.125751,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":157061071271},{"date":"2022-06-24","current":26.893443,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":168110914838},{"date":"2022-07-01","current":26.17138,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":163597298583},{"date":"2022-07-08","current":25.674111,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":160488864747},{"date":"2022-07-15","current":25.766071,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":161063712101},{"date":"2022-07-22","current":24.846463,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":155315238569},{"date":"2022-07-29","current":23.80824,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":157539125557},{"date":"2022-08-05","current":23.272571,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":153994601994},{"date":"2022-08-12","current":24.385859,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":161361232290},{"date":"2022-08-19","current":24.308413,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":160848771052},{"date":"2022-08-26","current":22.972467,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":152008814698},{"date":"2022-09-02","current":22.139921,"twenty":-24.131516,"median":22.294813,"eighty":60.876911,"marketCap":146499856390},{"date":"2022-09-09","current":22.640094,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":149809501885},{"date":"2022-09-16","current":23.078956,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":152713448900},{"date":"2022-09-23","current":22.817575,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":150983892222},{"date":"2022-09-30","current":22.940198,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":151795289182},{"date":"2022-10-07","current":22.491656,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":148827284512},{"date":"2022-10-14","current":22.788532,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":150791719257},{"date":"2022-10-21","current":23.301613,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":154186774959},{"date":"2022-10-28","current":25.54071,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":170535320356},{"date":"2022-11-04","current":26.188951,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":174863627979},{"date":"2022-11-11","current":25.251495,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":168604229262},{"date":"2022-11-18","current":25.746817,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":171911500215},{"date":"2022-11-25","current":26.34187,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":175884664649},{"date":"2022-12-02","current":26.970165,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":180079793576},{"date":"2022-12-09","current":26.205573,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":174974610226},{"date":"2022-12-16","current":24.430389,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":163121706273},{"date":"2022-12-23","current":24.23093,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":161789919312},{"date":"2022-12-30","current":23.918444,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":159703453073},{"date":"2023-01-06","current":24.267497,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":162034080255},{"date":"2023-01-13","current":24.104606,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":160946454236},{"date":"2023-01-20","current":24.649794,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":164586671930},{"date":"2023-01-27","current":24.08466,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":160813275540},{"date":"2023-02-03","current":26.118629,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":165252565410},{"date":"2023-02-10","current":25.329282,"twenty":-24.131516,"median":22.245911,"eighty":60.555486,"marketCap":160258364307},{"date":"2023-02-17","current":23.588424,"twenty":-24.131516,"median":22.245911,"eighty":60.138319,"marketCap":149243959795},{"date":"2023-02-24","current":23.279927,"twenty":-24.131516,"median":22.245911,"eighty":59.828291,"marketCap":147292098136},{"date":"2023-03-03","current":22.988016,"twenty":-24.131516,"median":22.245911,"eighty":59.303982,"marketCap":145445175275},{"date":"2023-03-10","current":21.79715,"twenty":-24.131516,"median":22.190955,"eighty":58.624659,"marketCap":137910569514},{"date":"2023-03-17","current":22.069158,"twenty":-24.131516,"median":22.143065,"eighty":57.674063,"marketCap":139631565816},{"date":"2023-03-24","current":22.499062,"twenty":-24.131516,"median":22.143065,"eighty":57.089646,"marketCap":142351566870},{"date":"2023-03-31","current":23.040928,"twenty":-24.122181,"median":22.147947,"eighty":56.818785,"marketCap":145779951237},{"date":"2023-04-06","current":23.210469,"twenty":-24.122181,"median":22.147947,"eighty":56.570827,"marketCap":146852635917},{"date":"2023-04-14","current":23.499685,"twenty":-24.131516,"median":22.143065,"eighty":54.708084,"marketCap":148682509782},{"date":"2023-04-21","current":23.114063,"twenty":-24.131516,"median":22.143065,"eighty":52.238402,"marketCap":146242677962},{"date":"2023-04-28","current":19.428023,"twenty":-24.131516,"median":22.133715,"eighty":43.587843,"marketCap":142038275000},{"date":"2023-05-05","current":19.201013,"twenty":-24.131516,"median":22.049255,"eighty":42.979111,"marketCap":140378605761},{"date":"2023-05-12","current":19.850434,"twenty":-24.131516,"median":21.75269,"eighty":40.909864,"marketCap":145126520293},{"date":"2023-05-19","current":18.879176,"twenty":-24.131516,"median":21.57897,"eighty":40.438819,"marketCap":138025656966},{"date":"2023-05-26","current":18.551592,"twenty":-24.131516,"median":21.441842,"eighty":40.037509,"marketCap":135630691229},{"date":"2023-06-02","current":18.586075,"twenty":-24.131516,"median":21.323413,"eighty":39.672401,"marketCap":135882792885},{"date":"2023-06-09","current":18.767108,"twenty":-24.131516,"median":21.067856,"eighty":39.30989,"marketCap":137206326582},{"date":"2023-06-16","current":18.583201,"twenty":-24.131516,"median":20.924495,"eighty":38.76535,"marketCap":135861784414},{"date":"2023-06-23","current":18.764234,"twenty":-24.14085,"median":20.774901,"eighty":37.956903,"marketCap":137185318111},{"date":"2023-06-30","current":18.390674,"twenty":-24.150185,"median":19.657906,"eighty":36.490198,"marketCap":134454216832},{"date":"2023-07-07","current":18.229755,"twenty":-24.150185,"median":19.568826,"eighty":35.727263,"marketCap":133277742434},{"date":"2023-07-14","current":17.896425,"twenty":-24.150185,"median":19.258484,"eighty":33.43663,"marketCap":130840759754},{"date":"2023-07-21","current":18.324582,"twenty":-24.15952,"median":19.11768,"eighty":31.771888,"marketCap":133971021990},{"date":"2023-07-28","current":15.932591,"twenty":-24.15952,"median":18.915095,"eighty":27.682522,"marketCap":126871220392},{"date":"2023-08-04","current":16.063766,"twenty":-24.15952,"median":18.814521,"eighty":27.240851,"marketCap":127915771852},{"date":"2023-08-11","current":16.079507,"twenty":-24.15952,"median":18.65504,"eighty":26.887057,"marketCap":128041118028},{"date":"2023-08-18","current":16.30513,"twenty":-24.15952,"median":18.600443,"eighty":26.661838,"marketCap":129837746540},{"date":"2023-08-25","current":16.076884,"twenty":-24.15952,"median":18.534351,"eighty":26.588154,"marketCap":128020226998},{"date":"2023-09-01","current":16.173954,"twenty":-24.15952,"median":18.403605,"eighty":26.567923,"marketCap":128793195079},{"date":"2023-09-08","current":15.733204,"twenty":-24.15952,"median":18.315962,"eighty":26.505248,"marketCap":125283502172},{"date":"2023-09-15","current":15.607275,"twenty":-24.15952,"median":17.92516,"eighty":26.451358,"marketCap":124280732770},{"date":"2023-09-22","current":15.499711,"twenty":-24.15952,"median":17.785793,"eighty":26.356016,"marketCap":123424200572},{"date":"2023-09-29","current":15.253101,"twenty":-24.15952,"median":17.14351,"eighty":26.308627,"marketCap":121460443826},{"date":"2023-10-06","current":14.801857,"twenty":-24.15952,"median":16.994886,"eighty":26.256528,"marketCap":117867186802},{"date":"2023-10-13","current":14.759881,"twenty":-24.15952,"median":16.912197,"eighty":26.215546,"marketCap":117532930335},{"date":"2023-10-20","current":14.817598,"twenty":-24.15952,"median":16.861517,"eighty":26.181912,"marketCap":117992532978},{"date":"2023-10-27","current":13.009187,"twenty":-24.15952,"median":16.75383,"eighty":26.13539,"marketCap":107781117593},{"date":"2023-11-03","current":12.557292,"twenty":-24.15952,"median":16.645066,"eighty":26.102322,"marketCap":104037163348},{"date":"2023-11-10","current":12.380463,"twenty":-24.15952,"median":16.606678,"eighty":26.050188,"marketCap":102572137774},{"date":"2023-11-17","current":12.486069,"twenty":-24.15952,"median":16.545514,"eighty":25.981328,"marketCap":103447083603},{"date":"2023-11-24","current":12.220826,"twenty":-24.15952,"median":16.468598,"eighty":25.948631,"marketCap":101249545241},{"date":"2023-12-01","current":12.1275,"twenty":-24.15952,"median":16.323182,"eighty":25.871656,"marketCap":100476337299},{"date":"2023-12-08","current":12.319064,"twenty":-24.15952,"median":16.284141,"eighty":25.822267,"marketCap":102063448338},{"date":"2023-12-15","current":12.640794,"twenty":-24.15952,"median":16.244457,"eighty":25.741743,"marketCap":104728980980},{"date":"2023-12-22","current":12.589219,"twenty":-24.15952,"median":16.206012,"eighty":25.671391,"marketCap":104301681854},{"date":"2023-12-29","current":12.579395,"twenty":-24.15952,"median":16.17133,"eighty":25.63392,"marketCap":104220291545},{"date":"2024-01-05","current":12.780784,"twenty":-24.15952,"median":16.126731,"eighty":25.574657,"marketCap":105888792893},{"date":"2024-01-12","current":12.3338,"twenty":-24.15952,"median":16.052442,"eighty":25.53878,"marketCap":102185533803},{"date":"2024-01-19","current":12.301873,"twenty":-24.15952,"median":15.981387,"eighty":25.384604,"marketCap":101921015296},{"date":"2024-01-26","current":12.183987,"twenty":-24.15952,"median":15.915318,"eighty":25.326357,"marketCap":100944331580},{"date":"2024-02-02","current":11.953127,"twenty":-24.15952,"median":15.848219,"eighty":25.326357,"marketCap":99031659303},{"date":"2024-02-09","current":12.350536,"twenty":-24.15952,"median":15.711339,"eighty":25.326357,"marketCap":99113049612},{"date":"2024-02-16","current":12.458223,"twenty":-24.15952,"median":15.581954,"eighty":25.326357,"marketCap":99977242239},{"date":"2024-02-23","current":12.934478,"twenty":-24.15952,"median":15.510205,"eighty":25.326357,"marketCap":103799187786},{"date":"2024-03-01","current":12.788326,"twenty":-24.15952,"median":15.476991,"eighty":25.323432,"marketCap":102626315608},{"date":"2024-03-08","current":13.425852,"twenty":-24.15952,"median":15.421006,"eighty":25.323432,"marketCap":107742464938},{"date":"2024-03-15","current":13.226783,"twenty":-24.15952,"median":15.29517,"eighty":25.323432,"marketCap":106144932143},{"date":"2024-03-22","current":12.999995,"twenty":-24.15952,"median":15.228111,"eighty":25.323432,"marketCap":104324958073},{"date":"2024-03-28","current":13.418293,"twenty":-24.15952,"median":15.187513,"eighty":25.323432,"marketCap":107681799135},{"date":"2024-04-05","current":12.981358,"twenty":-24.15952,"median":15.120443,"eighty":25.326357,"marketCap":104175397951},{"date":"2024-04-12","current":12.405531,"twenty":-24.15952,"median":15.050664,"eighty":25.326357,"marketCap":99554388080},{"date":"2024-04-19","current":12.198436,"twenty":-24.15952,"median":15.01354,"eighty":25.326357,"marketCap":97892445934},{"date":"2024-04-26","current":-14.73835,"twenty":-24.15952,"median":14.996944,"eighty":25.323432,"marketCap":90611374291},{"date":"2024-05-03","current":-14.408633,"twenty":-24.15952,"median":14.996944,"eighty":25.323432,"marketCap":88584274195},{"date":"2024-05-10","current":-14.751538,"twenty":-24.15952,"median":14.897686,"eighty":25.323432,"marketCap":90692458295},{"date":"2024-05-17","current":-14.543817,"twenty":-24.15952,"median":14.883186,"eighty":25.323432,"marketCap":89415385234},{"date":"2024-05-24","current":-13.696444,"twenty":-24.15952,"median":14.851704,"eighty":25.323432,"marketCap":84205737987},{"date":"2024-05-31","current":-13.271109,"twenty":-24.15952,"median":14.843629,"eighty":25.323432,"marketCap":81590778864},{"date":"2024-06-07","current":-13.478831,"twenty":-24.15952,"median":14.843629,"eighty":25.323432,"marketCap":82867851924},{"date":"2024-06-14","current":-13.676661,"twenty":-24.15952,"median":14.80891,"eighty":25.326357,"marketCap":84084111982},{"date":"2024-06-21","current":-13.531586,"twenty":-24.15952,"median":14.706868,"eighty":25.329282,"marketCap":83192187939},{"date":"2024-06-28","current":-13.686553,"twenty":-24.161675,"median":14.733375,"eighty":25.346437,"marketCap":84144924984},{"date":"2024-07-05","current":-13.208463,"twenty":-24.161675,"median":14.649759,"eighty":25.346437,"marketCap":81205629845},{"date":"2024-07-12","current":-13.435968,"twenty":-24.161675,"median":14.578971,"eighty":25.346437,"marketCap":82604328912},{"date":"2024-07-15","current":-13.34035,"twenty":-24.161675,"median":14.578971,"eighty":25.346437,"marketCap":82016469884},{"date":"2024-08-02","current":-14.930382,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":97659625724},{"date":"2024-08-09","current":-14.521245,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":94983464089},{"date":"2024-08-16","current":-15.221736,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":99565377191},{"date":"2024-08-23","current":-14.759908,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":96544558376},{"date":"2024-08-30","current":-15.410807,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":100802088250},{"date":"2024-09-06","current":-15.435603,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":100964279864},{"date":"2024-09-13","current":-14.952078,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":97801543386},{"date":"2024-09-20","current":-15.193841,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":99382911625},{"date":"2024-09-27","current":-15.534788,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":101613046321},{"date":"2024-10-04","current":-16.799391,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":109884818647},{"date":"2024-10-11","current":-16.241478,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":106235507327},{"date":"2024-10-18","current":-16.48324,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":107816875566},{"date":"2024-10-25","current":-16.402653,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":107289752819},{"date":"2024-10-31","current":-16.322065,"twenty":-24.197578,"median":14.812351,"eighty":25.39607,"marketCap":106762630073},{"date":"2024-11-08","current":-15.288171,"twenty":-24.199732,"median":13.697044,"eighty":25.3977,"marketCap":110961545834},{"date":"2024-11-15","current":-16.347249,"twenty":-24.199732,"median":13.400607,"eighty":25.3977,"marketCap":118648335429},{"date":"2024-11-22","current":-16.2718,"twenty":-24.199732,"median":13.207884,"eighty":25.3977,"marketCap":118100727727},{"date":"2024-11-29","current":-16.548446,"twenty":-24.199732,"median":13.07937,"eighty":25.3977,"marketCap":120108622634},{"date":"2024-12-06","current":-16.442259,"twenty":-24.199732,"median":13.01341,"eighty":25.3977,"marketCap":119337915498},{"date":"2024-12-13","current":-15.726892,"twenty":-24.199732,"median":12.968664,"eighty":25.320507,"marketCap":114145783212},{"date":"2024-12-20","current":-15.732481,"twenty":-24.199732,"median":12.88985,"eighty":25.094333,"marketCap":114186346746},{"date":"2024-12-27","current":-16.207529,"twenty":-24.199732,"median":12.836673,"eighty":24.91965,"marketCap":117634247092},{"date":"2025-01-03","current":-15.869407,"twenty":-24.199732,"median":12.825525,"eighty":24.830114,"marketCap":115180153316},{"date":"2025-01-10","current":-15.874995,"twenty":-24.201887,"median":12.736577,"eighty":24.700357,"marketCap":115220716849},{"date":"2025-01-17","current":-15.754836,"twenty":-24.201887,"median":12.665354,"eighty":24.382395,"marketCap":114348600880},{"date":"2025-01-24","current":-16.526091,"twenty":-24.201887,"median":12.629443,"eighty":24.315777,"marketCap":119946368500},{"date":"2025-01-31","current":-16.526091,"twenty":-24.201887,"median":12.589219,"eighty":24.176109,"marketCap":119946368500},{"date":"2025-02-07","current":-16.045454,"twenty":-24.201887,"median":12.557292,"eighty":24.139507,"marketCap":116457904621},{"date":"2025-02-14","current":-12.693406,"twenty":-24.201887,"median":12.48999,"eighty":24.058649,"marketCap":113580593927},{"date":"2025-02-21","current":-12.652584,"twenty":-24.201887,"median":12.441862,"eighty":24.03394,"marketCap":113215317763},{"date":"2025-02-28","current":-13.33522,"twenty":-24.201887,"median":12.405023,"eighty":23.957965,"marketCap":119323546952},{"date":"2025-03-07","current":-13.648189,"twenty":-24.204041,"median":12.35322,"eighty":23.91379,"marketCap":122123997544},{"date":"2025-03-14","current":-13.670868,"twenty":-24.204041,"median":12.333293,"eighty":23.792996,"marketCap":122326928746},{"date":"2025-03-21","current":-13.702619,"twenty":-24.204041,"median":12.308013,"eighty":23.674229,"marketCap":122611032429},{"date":"2025-03-28","current":-13.357899,"twenty":-24.204041,"median":12.274857,"eighty":23.602452,"marketCap":119526478154},{"date":"2025-04-04","current":-13.14819,"twenty":-24.204041,"median":12.234334,"eighty":23.545063,"marketCap":117650007992},{"date":"2025-04-11","current":-11.474536,"twenty":-24.201887,"median":12.193385,"eighty":23.482347,"marketCap":102674150870},{"date":"2025-04-17","current":-11.224398,"twenty":-24.201887,"median":12.165443,"eighty":23.454761,"marketCap":100435911354},{"date":"2025-04-25","current":18.285308,"twenty":-24.204041,"median":12.026806,"eighty":23.356243,"marketCap":99088084638},{"date":"2025-05-02","current":18.63081,"twenty":-24.204041,"median":12.026806,"eighty":23.317376,"marketCap":100960358984},{"date":"2025-05-09","current":17.605571,"twenty":-24.204041,"median":12.026806,"eighty":23.272318,"marketCap":95404588372},{"date":"2025-05-16","current":17.203737,"twenty":-24.204041,"median":12.026806,"eighty":23.222393,"marketCap":93227051906},{"date":"2025-05-23","current":17.661903,"twenty":-24.204041,"median":12.026806,"eighty":23.160274,"marketCap":95709850494},{"date":"2025-05-30","current":17.96985,"twenty":-24.204041,"median":12.026806,"eighty":23.102683,"marketCap":97378616758},{"date":"2025-06-06","current":17.966094,"twenty":-24.204041,"median":12.026806,"eighty":23.03988,"marketCap":97358265950},{"date":"2025-06-13","current":19.036399,"twenty":-24.204041,"median":12.026806,"eighty":23.001392,"marketCap":103158246258},{"date":"2025-06-20","current":17.590549,"twenty":-24.206195,"median":12.014526,"eighty":22.956332,"marketCap":95323185140},{"date":"2025-06-27","current":17.519195,"twenty":-24.206195,"median":12.014526,"eighty":22.892874,"marketCap":94936519786},{"date":"2025-07-03","current":17.620593,"twenty":-24.206195,"median":12.014526,"eighty":22.817575,"marketCap":95485991605},{"date":"2025-07-11","current":18.221465,"twenty":-24.206195,"median":12.014526,"eighty":22.701406,"marketCap":98742120901},{"date":"2025-07-18","current":18.048714,"twenty":-24.206195,"median":12.014526,"eighty":22.649775,"marketCap":97805983728},{"date":"2025-07-25","current":18.379194,"twenty":-24.206195,"median":12.014526,"eighty":22.556783,"marketCap":99596854841},{"date":"2025-08-01","current":17.456793,"twenty":-24.206195,"median":12.014526,"eighty":22.431005,"marketCap":88139349881},{"date":"2025-08-08","current":18.286268,"twenty":-24.177472,"median":12.08226,"eighty":22.400619,"marketCap":92327369611},{"date":"2025-08-15","current":19.273953,"twenty":-24.112846,"median":12.183987,"eighty":22.400619,"marketCap":97314187414},{"date":"2025-08-22","current":19.523897,"twenty":-24.0554,"median":12.220826,"eighty":22.400619,"marketCap":98576157634},{"date":"2025-08-29","current":18.899036,"twenty":-23.982843,"median":12.274273,"eighty":22.400619,"marketCap":95421232085},{"date":"2025-09-05","current":18.82244,"twenty":-23.946253,"median":12.303101,"eighty":22.403337,"marketCap":95034499276},{"date":"2025-09-12","current":19.165106,"twenty":-23.839978,"median":12.319064,"eighty":22.400619,"marketCap":96764619738},{"date":"2025-09-19","current":18.383021,"twenty":-23.674822,"median":12.338712,"eighty":22.400619,"marketCap":92815874212},{"date":"2025-09-26","current":17.500152,"twenty":-23.592711,"median":12.357546,"eighty":22.400619,"marketCap":88358269727},{"date":"2025-10-03","current":18.435429,"twenty":-23.480943,"median":12.407479,"eighty":22.400619,"marketCap":93080480871},{"date":"2025-10-10","current":18.012136,"twenty":-23.373232,"median":12.486069,"eighty":22.400619,"marketCap":90943273241},{"date":"2025-10-17","current":17.49209,"twenty":-23.294244,"median":12.530276,"eighty":22.400619,"marketCap":88317561010},{"date":"2025-10-24","current":17.66947,"twenty":-23.222437,"median":12.579395,"eighty":22.400619,"marketCap":89213152779},{"date":"2025-10-31","current":15.376152,"twenty":-23.143449,"median":12.608867,"eighty":22.400619,"marketCap":92856582929},{"date":"2025-11-07","current":15.71902,"twenty":-22.870582,"median":12.65553,"eighty":22.400619,"marketCap":94927163649},{"date":"2025-11-14","current":16.393222,"twenty":-22.438742,"median":12.730369,"eighty":22.400619,"marketCap":98998669703},{"date":"2025-11-21","current":15.486421,"twenty":-16.752438,"median":12.823604,"eighty":22.400619,"marketCap":93522494060},{"date":"2025-11-28","current":16.58537,"twenty":-16.685372,"median":12.831164,"eighty":22.400619,"marketCap":100159048928},{"date":"2025-12-05","current":17.512398,"twenty":-16.548446,"median":12.905591,"eighty":22.400619,"marketCap":105757369752},{"date":"2025-12-12","current":17.259572,"twenty":-16.520502,"median":12.972348,"eighty":22.400619,"marketCap":104230554982},{"date":"2025-12-19","current":17.977597,"twenty":-16.472997,"median":13.017634,"eighty":22.400619,"marketCap":108566708929},{"date":"2025-12-26","current":18.442797,"twenty":-16.434176,"median":13.073071,"eighty":22.400619,"marketCap":111376048107},{"date":"2026-01-02","current":18.183229,"twenty":-16.414315,"median":13.188985,"eighty":22.400619,"marketCap":109808518276},{"date":"2026-01-09","current":18.843947,"twenty":-16.374704,"median":13.382921,"eighty":22.400619,"marketCap":113798594209},{"date":"2026-01-16","current":19.086659,"twenty":-16.353061,"median":13.69609,"eighty":22.400619,"marketCap":115264336388},{"date":"2026-01-23","current":18.52033,"twenty":-16.325165,"median":14.759881,"eighty":22.400619,"marketCap":111844271303},{"date":"2026-01-30","current":18.297843,"twenty":-16.272473,"median":14.817598,"eighty":22.400619,"marketCap":110500674305},{"date":"2026-02-06","current":17.177207,"twenty":-16.266274,"median":14.914668,"eighty":22.400619,"marketCap":121168020167},{"date":"2026-02-13","current":17.27533,"twenty":-16.266274,"median":15.187513,"eighty":22.400619,"marketCap":121860176196},{"date":"2026-02-20","current":17.408472,"twenty":-16.266274,"median":15.368435,"eighty":22.400619,"marketCap":122799364411},{"date":"2026-02-27","current":17.639431,"twenty":-16.266274,"median":15.435855,"eighty":22.400619,"marketCap":124428543375},{"date":"2026-03-06","current":17.535499,"twenty":-16.266274,"median":15.513389,"eighty":22.400619,"marketCap":123695412841},{"date":"2026-03-13","current":17.01873,"twenty":-16.266274,"median":15.649251,"eighty":22.400619,"marketCap":120050124909},{"date":"2026-03-20","current":16.776224,"twenty":-16.266274,"median":15.733204,"eighty":22.400619,"marketCap":118339486997},{"date":"2026-03-27","current":17.201636,"twenty":-16.266274,"median":15.863974,"eighty":22.400619,"marketCap":121340338090},{"date":"2026-04-02","current":17.867356,"twenty":-16.266274,"median":15.908979,"eighty":22.400619,"marketCap":126036329637},{"date":"2026-04-10","current":17.213213,"twenty":-16.266274,"median":15.985061,"eighty":22.400619,"marketCap":121422007508},{"date":"2026-04-17","current":17.065597,"twenty":-16.266274,"median":16.099944,"eighty":22.400619,"marketCap":120380722426},{"date":"2026-04-24","current":17.082964,"twenty":-16.179488,"median":16.17133,"eighty":22.400619,"marketCap":120503226554},{"date":"2026-05-01","current":17.004639,"twenty":-16.118108,"median":16.242165,"eighty":22.400619,"marketCap":123708751218},{"date":"2026-05-08","current":15.789211,"twenty":-16.03691,"median":16.265124,"eighty":22.400619,"marketCap":114866507643},{"date":"2026-05-15","current":15.935173,"twenty":-15.883379,"median":16.265124,"eighty":22.400619,"marketCap":115928384692},{"date":"2026-05-22","current":16.715511,"twenty":-15.830285,"median":16.286765,"eighty":22.400619,"marketCap":121605342758},{"date":"2026-05-29","current":15.974471,"twenty":-15.759799,"median":16.310377,"eighty":22.403337,"marketCap":116214274666},{"date":"2026-06-05","current":15.887455,"twenty":-15.710126,"median":16.30513,"eighty":22.400619,"marketCap":115581232580}],"updateTime":1780853059404},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMY\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1145683800","title":"异动解读｜施贵宝盘中上涨3.13%，多重利好叠加行业回暖共振","url":"https://stock-news.laohu8.com/highlight/detail?id=1145683800","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145683800?lang=zh_cn&edition=fundamental","pubTime":"2026-06-04 22:35","pubTimestamp":1780583737,"startTime":"0","endTime":"0","summary":"6月4日，施贵宝盘中上涨3.13%，报56.09美元/股，成交额1.59亿美元。此外，杰富瑞将公司目标价从70美元上调至73美元，维持买入评级。当日制药行业整体表现强势，礼来涨4.54%，诺和诺德涨4.43%，默沙东涨3.62%，板块联动亦对股价形成支撑。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640942212","title":"健康快讯：放射性植入物可改善脑癌手术后的治疗效果","url":"https://stock-news.laohu8.com/highlight/detail?id=2640942212","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640942212?lang=zh_cn&edition=fundamental","pubTime":"2026-06-03 00:56","pubTimestamp":1780419386,"startTime":"0","endTime":"0","summary":"研究人员称，这种注入放射性物质的薄层胶原蛋白GammaTile被植入手术切除肿瘤后留下的空腔中，随即开始杀灭任何残留的肿瘤细胞。放射性逐渐减弱，而该植入片会被人体吸收。在一项晚期临床试验中，230名可手术脑转移瘤患者在手术后分别接受了GammaTile植入或标准放射治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nL4S42A1HT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2361044949.HKD","BK4504","LU1061106388.HKD","LU0942090050.USD","IE00BVYPNV92.GBP","LU1043141396.HKD","JNJ","LU0912757837.SGD","LU1551013342.USD","IE000M9KFDE8.USD","LU1670710588.SGD","LU1941712264.USD","LU0211331839.USD","LU2430703178.SGD","LU0859254822.USD","LU2242646821.SGD","LU2433249047.HKD","LU1244550221.USD","LU1244550577.SGD","LU1868836591.USD","LU1162221912.USD","LU2471134879.HKD","LU1974910355.USD","LU1894683348.USD","LU1629891620.HKD","LU2456880835.USD","LU0882574055.USD","SG9999013999.USD","BK4566","LU2505996681.GBP","IE00BJJMRZ35.SGD","LU0820561818.USD","AMGN","LU0426412945.USD","LU0208291251.USD","BK4550","LU1670711040.USD","IE00B7SZLL34.SGD","LU0345770308.USD","LU1116320737.USD","LU1228905540.USD","IE00BVYPNW00.USD","LU0432979614.USD","LU0124676726.USD","LU0980610538.SGD","LU0234572021.USD","LU1066053197.SGD","IE00BBT3K403.USD","IE00B3T34201.USD","LU0965508806.USD","LU1917777945.USD","LU2357627491.SGD","LU0683600562.USD","LU0321505439.SGD","LU1059921491.USD","LU1670710661.SGD","LU1934455194.USD","LU2112291526.USD","IE000SO60NU8.SGD","SG9999014542.SGD","LU1043141123.HKD","LU2471134523.USD","SG9999015358.SGD","LU0889565916.HKD","LU0320765992.SGD","LU1883839398.USD","LU2468319806.SGD","IE00B3PB1722.GBP","LU0234570918.USD","LU2324357040.USD","LU0868494617.USD","LU0070217475.USD","LU0289739699.SGD","LU0061475181.USD","LU0965509010.AUD","LU1934455277.USD","LU0640476718.USD","LU0820561909.HKD","LU1868836757.USD","LU1983299246.USD","IE00BN8TJ469.HKD","LU1057294990.SGD","LU2750360997.AUD","LU0320765646.SGD","LU2129689514.USD","BMY","LU0466842654.USD","LU1035773651.USD","LU1037948897.HKD","LU0006306889.USD","LU0266013472.USD","LU1674673691.USD","LU2236285917.USD","LU2213496289.HKD","LU2347655156.SGD","LU0965509101.SGD","IE00BZ1G4Q59.USD","LU1074936037.SGD","LU1228905037.USD","LU1291159041.SGD","LU2125909247.SGD","04332","LU0426417589.USD","LU1430594728.SGD","LU0306806265.USD","LU1989772840.SGD","LU1670711123.USD","LU0122379950.USD","LU2106854487.HKD","LU0477156953.USD","MRK","LU0265550359.USD","IE00BGHQF631.EUR","LU1023059063.AUD","LU1093756325.SGD","LU0114720955.EUR","IE00BFXG1179.USD","LU2023250330.USD","IE00B2B36J28.USD","LU0965509283.SGD","LU1280957306.USD","LU2125909593.SGD","LU2430703095.HKD","LU0792757196.USD","LU0795875169.SGD","LU1066051811.HKD","LU2491049909.HKD","MRNY","SG9999014567.USD","LU0237698245.USD","LU0238689110.USD","LU0689626769.HKD","SG9999002232.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","LU2023250843.SGD","IE0009355771.USD","BK4533","LU1032466523.USD","IE00B19Z3581.USD","IE00BLSP4452.SGD","LU1037948541.HKD","SG9999001176.USD","IE00BFTCPJ56.SGD","LU1267930813.SGD","LU1732800096.USD","LU1506573853.SGD","LU2756315318.SGD","LU1674673428.USD","IE000WAW04H5.SGD","LU1221951046.USD","LU2361045086.USD","LU0267386448.USD","IE00BLSP4239.USD","LU1221951129.SGD","LU2023250504.SGD","LU2750360641.GBP","SGXZ57979304.SGD","LU0321505868.SGD","LU1032955483.USD","BK4139","IE000F7OJYX1.SGD","LU0306807586.USD","IE00B42XCP33.USD","LU0994945656.USD","LU0109394709.USD","IE000BZT7R73.USD","IE0000B7K699.USD","LU1868837300.USD","LU2129689431.USD","LU0345769128.USD","LU1571399168.USD","LU2471134796.USD","LU0265550946.USD","LU2361044865.SGD","LU2505996509.AUD","LU1894683264.USD","MRNA","BK4551","LU1718418525.SGD","LU1069347547.HKD","LU2756315664.SGD","LU1196500208.SGD","BK4592","LU0345769631.USD","IE00BKVL7J92.USD","LU0868494708.USD","LU0225771236.USD","LU0795875086.SGD","BK4581","LU0203347892.USD","LU0053666078.USD","LU2491050154.USD","LU0545562505.USD","LU0861579265.USD","LU0943347566.SGD","LU0106261372.USD","LU0130517989.USD","LU1116320901.HKD","BK4532","LU0985320562.USD","LU1261432733.SGD","LU1585245621.USD","LU2125154935.USD","LU2491050071.SGD","MRNX","BK4568","LU0964807845.USD","LU0456855351.SGD","SG9999001440.SGD","LU2089984988.USD","LU2487616109.SGD","BK4534","IE00BDGV0183.EUR","LU1121112475.USD","LU2417539215.USD","LU2242652126.USD","LU1935042991.SGD","BK4501","SG9999001176.SGD","LU1941712348.USD","LU0648001328.SGD","LU0787776722.HKD","LU1989771016.USD","LU0689472784.USD","IE000MB6IJN5.SGD","LU0096364046.USD","LU0203345920.USD","LU0225284248.USD","LU1934455863.HKD","LU1989772923.USD","SG9999002224.SGD","LU0345770993.USD","LU1145028129.USD","BK4516","LU1066051498.USD","LU1496350502.SGD","LU0820562030.AUD","LU1699723380.USD","LU2461242641.AUD","LU1093756168.USD","LU2133065610.SGD","IE00B4R5TH58.HKD","LU1778281490.HKD","BK4559","SG9999014559.SGD","LU2360032135.SGD","LU2471134952.CNY","LU2403377893.USD","LU1323610961.USD","LU0210536198.USD","LU2592432038.USD","LU2125154778.USD","LU0210528500.USD","IE0034235303.USD","LU1923622614.USD","LU0058720904.USD","IE00B1BXHZ80.USD","LU1914381329.SGD","LU1551013425.SGD","LU0320765489.SGD","LU1201861249.SGD","LU1929549753.HKD","LU0985481810.HKD","BK4588","LU2896262040.SGD","LU0889566641.SGD","LU2602419157.SGD","LU0098860793.USD","LU2430703251.USD","BK4585","LU1244550494.USD","LU1868836914.USD","BK4007","LU2129689605.HKD","IE00BJT1NW94.SGD","SG9999014575.USD","LU1868837136.USD","SG9999015341.SGD","IE0002270589.USD","LU0130102774.USD","BK4599","LU1066051225.USD","LU1732799900.SGD","LU0070302665.USD","IE0002141913.USD","IE0001KFT4U8.USD","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134800758","title":"百时美施贵宝：Iza-Bren在重度经治患者群体中展现可控安全性，未观察到新的安全信号","url":"https://stock-news.laohu8.com/highlight/detail?id=1134800758","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134800758?lang=zh_cn&edition=fundamental","pubTime":"2026-06-02 20:04","pubTimestamp":1780401860,"startTime":"0","endTime":"0","summary":"百时美施贵宝（Bristol-Myers Squibb）公布的数据显示，其药物组合Iza-Bren在重度经治的患者群体中表现出可控的安全性特征。研究期间，未观察到任何新的安全信号。这一结果对于此前已接受过多种治疗方案的患者而言，具有积极的临床意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0432979614.USD","BK4559","LU0267386448.USD","IE0002141913.USD","LU2125154935.USD","LU1074936037.SGD","LU0096364046.USD","LU0237698245.USD","LU1571399168.USD","LU1868836914.USD","LU0306806265.USD","LU1670711123.USD","LU2125154778.USD","LU1868837300.USD","LU0868494617.USD","BK4534","LU1430594728.SGD","LU1291159041.SGD","LU1983299246.USD","IE00BFTCPJ56.SGD","LU0321505439.SGD","IE00B2B36J28.USD","LU0985481810.HKD","LU1585245621.USD","LU1989771016.USD","BK4588","LU1883839398.USD","LU0114720955.EUR","LU1323610961.USD","IE00BJJMRZ35.SGD","LU1868836757.USD","IE00BSNM7G36.USD","BK4532","LU0225284248.USD","LU1670710588.SGD","LU1670711040.USD","LU1868836591.USD","BK4585","IE00BJT1NW94.SGD","LU1093756325.SGD","LU2133065610.SGD","LU0882574055.USD","BMY","BK4007","LU1670710661.SGD","LU1032466523.USD","IE0009355771.USD","LU1718418525.SGD","LU0225771236.USD","LU2242652126.USD","LU2242646821.SGD","LU0061475181.USD","LU2360032135.SGD","LU0306807586.USD","LU0321505868.SGD","LU1093756168.USD","LU1261432733.SGD","BK4581","LU1868837136.USD","LU0456855351.SGD","IE00BFXG1179.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130883268","title":"施贵宝Izalontamab Brengitecan在TNBC和ESCC中展现显著的OS与PFS改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1130883268","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130883268?lang=zh_cn&edition=fundamental","pubTime":"2026-06-02 20:01","pubTimestamp":1780401706,"startTime":"0","endTime":"0","summary":"施贵宝公司宣布，其候选药物Izalontamab Brengitecan在三阴性乳腺癌和食管鳞状细胞癌的临床试验中，取得了总生存期与无进展生存期的显著改善。这一积极数据为相关癌症患者带来了新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU0225284248.USD","LU0306807586.USD","LU1670711040.USD","LU2133065610.SGD","LU0061475181.USD","BK4532","LU0868494617.USD","LU1983299246.USD","LU1670711123.USD","LU1093756168.USD","LU1571399168.USD","BK4559","LU1670710661.SGD","LU0096364046.USD","LU1718418525.SGD","LU1883839398.USD","LU0985481810.HKD","IE0009355771.USD","LU1323610961.USD","LU1868836914.USD","LU0321505439.SGD","LU0114720955.EUR","IE00BJJMRZ35.SGD","LU1868837300.USD","LU1989771016.USD","IE00BJT1NW94.SGD","BK4585","LU2125154778.USD","LU1261432733.SGD","BK4007","LU1074936037.SGD","BMY","IE00BFTCPJ56.SGD","LU0432979614.USD","LU0456855351.SGD","LU1868836591.USD","LU2242652126.USD","IE00BSNM7G36.USD","IE00BFXG1179.USD","LU0267386448.USD","LU1868836757.USD","LU2242646821.SGD","LU1093756325.SGD","LU2125154935.USD","LU0321505868.SGD","LU1032466523.USD","BK4588","LU1430594728.SGD","IE0002141913.USD","LU0225771236.USD","LU1291159041.SGD","LU0882574055.USD","LU2360032135.SGD","LU0237698245.USD","BK4581","LU1670710588.SGD","LU1868837136.USD","LU0306806265.USD","IE00B2B36J28.USD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132733869","title":"异动解读｜施贵宝盘中下跌3.1%，报55.2美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1132733869","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132733869?lang=zh_cn&edition=fundamental","pubTime":"2026-06-01 22:23","pubTimestamp":1780323800,"startTime":"0","endTime":"0","summary":"6月1日，施贵宝盘中下跌3.1%，报55.2美元/股，成交额1.68亿美元。施贵宝所在的制药行业中，整体表现疲软，个股中，礼来跌2.2%，强生跌1.51%，辉瑞跌2.08%，默沙东跌2.84%，诺和诺德跌2.39%。百时美施贵宝公司是一家生物制药公司，专注于创新药物的发现、开发、许可、生产、营销和销售，优先关注肿瘤学、血液学、免疫学、心血管和神经科学等领域的变革性药物。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124846858","title":"FDA优先审评施贵宝Camzyos补充新药申请，用于治疗青少年症状性梗阻性肥厚型心肌病","url":"https://stock-news.laohu8.com/highlight/detail?id=1124846858","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124846858?lang=zh_cn&edition=fundamental","pubTime":"2026-06-01 19:00","pubTimestamp":1780311638,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局已接受施贵宝（Bristol-Myers Squibb）提交的Camzyos（Mavacamten）补充新药申请，并授予其优先审评资格。该申请旨在扩展该药物的适应症，用于治疗青少年患者的症状性梗阻性肥厚型心肌病。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0432979614.USD","BK4559","LU0267386448.USD","IE0002141913.USD","LU2125154935.USD","LU1074936037.SGD","LU0096364046.USD","LU0237698245.USD","LU1571399168.USD","LU1868836914.USD","LU0306806265.USD","LU1670711123.USD","LU2125154778.USD","LU1868837300.USD","LU0868494617.USD","BK4534","LU1430594728.SGD","LU1291159041.SGD","LU1983299246.USD","IE00BFTCPJ56.SGD","LU0321505439.SGD","IE00B2B36J28.USD","LU0985481810.HKD","LU1585245621.USD","LU1989771016.USD","BK4588","LU1883839398.USD","LU0114720955.EUR","LU1323610961.USD","IE00BJJMRZ35.SGD","LU1868836757.USD","IE00BSNM7G36.USD","BK4532","LU0225284248.USD","LU1670710588.SGD","LU1670711040.USD","LU1868836591.USD","BK4585","IE00BJT1NW94.SGD","LU1093756325.SGD","LU2133065610.SGD","LU0882574055.USD","BMY","BK4007","LU1670710661.SGD","LU1032466523.USD","IE0009355771.USD","LU1718418525.SGD","LU0225771236.USD","LU2242652126.USD","LU2242646821.SGD","LU0061475181.USD","LU2360032135.SGD","LU0306807586.USD","LU0321505868.SGD","LU1093756168.USD","LU1261432733.SGD","BK4581","LU1868837136.USD","LU0456855351.SGD","IE00BFXG1179.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120138167","title":"施贵宝免疫疗法组合获批用于治疗既往未治疗的III/IV期经典霍奇金淋巴瘤成人与青少年患者（12岁及以上）","url":"https://stock-news.laohu8.com/highlight/detail?id=1120138167","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120138167?lang=zh_cn&edition=fundamental","pubTime":"2026-06-01 18:59","pubTimestamp":1780311545,"startTime":"0","endTime":"0","summary":"施贵宝公司宣布，其免疫疗法组合方案已获得监管批准，适用于治疗既往未接受过治疗的III期或IV期经典霍奇金淋巴瘤（CHL）患者，覆盖年龄在12岁及以上的成人和青少年人群。这一批准标志着该疗法应用范围的进一步扩大，为更广泛的患者群体提供了新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1670710661.SGD","LU1093756168.USD","BK4585","BK4007","LU0114720955.EUR","LU0868494617.USD","LU0306807586.USD","LU1670711123.USD","LU1868836757.USD","LU1291159041.SGD","LU1868837300.USD","LU2125154935.USD","LU0985481810.HKD","IE00B2B36J28.USD","LU1983299246.USD","LU1074936037.SGD","LU1868837136.USD","LU0225771236.USD","LU1323610961.USD","LU0267386448.USD","BK4581","IE00BSNM7G36.USD","LU2360032135.SGD","LU0225284248.USD","LU2242652126.USD","LU1571399168.USD","LU1585245621.USD","LU1670711040.USD","BK4534","LU0096364046.USD","LU0306806265.USD","LU1093756325.SGD","LU0456855351.SGD","LU1989771016.USD","LU0882574055.USD","IE00BFTCPJ56.SGD","LU1261432733.SGD","BK4532","LU2242646821.SGD","BMY","IE00BFXG1179.USD","LU2133065610.SGD","LU0061475181.USD","BK4588","IE0002141913.USD","LU1032466523.USD","LU1868836914.USD","IE0009355771.USD","LU1718418525.SGD","LU1883839398.USD","LU0432979614.USD","LU1670710588.SGD","IE00BJJMRZ35.SGD","LU2125154778.USD","IE00BJT1NW94.SGD","LU0321505439.SGD","LU0237698245.USD","LU0321505868.SGD","BK4559","LU1868836591.USD","LU1430594728.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168315798","title":"施贵宝宣布欧狄沃®联合AVD疗法获欧盟扩大标签，获批用于一线治疗晚期经典型霍奇金淋巴瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=1168315798","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168315798?lang=zh_cn&edition=fundamental","pubTime":"2026-06-01 18:55","pubTimestamp":1780311348,"startTime":"0","endTime":"0","summary":"施贵宝宣布，其欧狄沃®（纳武利尤单抗）联合AVD化疗方案，已获得欧盟监管机构批准扩大标签，可用于一线治疗晚期经典型霍奇金淋巴瘤。这一决定标志着该免疫联合疗法在欧洲的应用范围得到进一步拓展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BFXG1179.USD","LU1032466523.USD","LU1074936037.SGD","LU0306807586.USD","BMY","LU1670711123.USD","LU1718418525.SGD","LU1868836757.USD","LU2125154778.USD","LU1093756168.USD","LU1261432733.SGD","BK4585","LU1571399168.USD","LU2242646821.SGD","IE0009355771.USD","LU1430594728.SGD","LU0237698245.USD","LU0225771236.USD","LU0432979614.USD","LU2133065610.SGD","LU0306806265.USD","BK4559","BK4534","IE0002141913.USD","LU2125154935.USD","IE00BSNM7G36.USD","IE00BJT1NW94.SGD","LU0985481810.HKD","LU0114720955.EUR","LU0267386448.USD","LU2360032135.SGD","LU1323610961.USD","LU1670711040.USD","IE00B2B36J28.USD","LU0321505439.SGD","LU1868837300.USD","BK4532","LU1670710661.SGD","LU1989771016.USD","LU0061475181.USD","LU1291159041.SGD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU2242652126.USD","BK4581","BK4007","LU0321505868.SGD","LU0456855351.SGD","LU1868836914.USD","LU1670710588.SGD","IE00BJJMRZ35.SGD","LU1868837136.USD","LU1983299246.USD","LU0225284248.USD","LU1883839398.USD","LU1093756325.SGD","LU0096364046.USD","LU0882574055.USD","LU1868836591.USD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639760958","title":"Incyte的血液癌症联合用药方案可降低疾病进展风险，但副作用发生率较高","url":"https://stock-news.laohu8.com/highlight/detail?id=2639760958","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639760958?lang=zh_cn&edition=fundamental","pubTime":"2026-05-30 20:00","pubTimestamp":1780142435,"startTime":"0","endTime":"0","summary":"Incyte的血液癌症联合用药方案可降低疾病进展风险，但副作用发生率较高Monjuvi联合疗法在DLBCL临床试验中降低了疾病进展风险Monjuvi联合疗法严重不良事件和停药率较高，但总体死亡率较低Incyte计划申请扩大美国批准范围，用于一线治疗Christy Santhosh. 路透5月30日 - Incyte公司的 INCY.O Monjuvi 作为多药方案的一部分，该方案包含针对侵袭性非霍奇金淋巴瘤的标准化疗方案，与仅使用标准化疗相比，可将疾病进展、复发或死亡的风险降低25%，但因副作用导致的研究退出率较高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nL4S427034:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BSNM7G36.USD","BMY","LU1718418525.SGD","LU1323610961.USD","LU1868837136.USD","LU1585245621.USD","LU1093756325.SGD","LU1868836914.USD","BK4581","LU0321505439.SGD","LU2242646821.SGD","IE0009355771.USD","BK4534","LU0114720955.EUR","LU0868494617.USD","LU1291159041.SGD","LU1093756168.USD","LU0061475181.USD","INCY","LU0267386448.USD","IE00BFXG1179.USD","BK4007","LU0306807586.USD","LU1868836757.USD","LU1983299246.USD","LU0096364046.USD","LU1261432733.SGD","LU0225771236.USD","LU0882574055.USD","BK4559","LU1868836591.USD","LU1670710661.SGD","LU1571399168.USD","LU0225284248.USD","LU0237698245.USD","IE00B2B36J28.USD","LU1670710588.SGD","LU1868837300.USD","LU2133065610.SGD","IE00BJT1NW94.SGD","LU1074936037.SGD","LU2242652126.USD","LU2360032135.SGD","LU1032466523.USD","LU0456855351.SGD","LU0321505868.SGD","BK4139","BK4588","LU2125154935.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639622049","title":"Replimune的皮肤癌药物在美国获批迎来第三次机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2639622049","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639622049?lang=zh_cn&edition=fundamental","pubTime":"2026-05-29 20:12","pubTimestamp":1780056779,"startTime":"0","endTime":"0","summary":"更新版 4-Replimune的皮肤癌药物在美国获批迎来第三次机会重启申请的消息传出后，股价暴涨86%《华尔街日报》称白宫敦促卫生官员重新审查FDA的驳回决定 Replimune称FDA将优先审查重新提交的申请分析师指出，FDA立场转变的动因尚不明确重写第1段，在第4-5段中补充《华尔街日报》报道的细节，第6段尝试获取评论，最后为股价及要点。路透5月30日 - Replimune公司周五表示，在与美国监管机构达成协议后，计划于未来数日第三次申请其实验性皮肤癌药物的批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nL4S42613K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1074936037.SGD","LU2125154935.USD","SRPU","MRNX","LU0225771236.USD","LU1093756325.SGD","LU2242646821.SGD","BK4534","LU1868837300.USD","LU1571399168.USD","LU1670711123.USD","IE00BFTCPJ56.SGD","LU0306806265.USD","IE00BFXG1179.USD","REPL","LU1868836914.USD","SRPT","LU0432979614.USD","MRNA","LU0061475181.USD","BK4532","BK4551","LU1868836591.USD","LU1868836757.USD","LU1883839398.USD","LU1670711040.USD","LU0868494617.USD","LU0114720955.EUR","LU1032466523.USD","LU1430594728.SGD","BK4548","IE0002141913.USD","IE0009355771.USD","LU1670710661.SGD","LU2242652126.USD","MRNY","BK4559","BK4568","BK4007","LU1291159041.SGD","LU0096364046.USD","LU0321505868.SGD","LU1261432733.SGD","LU0237698245.USD","LU1718418525.SGD","LU1983299246.USD","BMY","IE00BJJMRZ35.SGD","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639221346","title":"百时美施贵宝的药物可延缓难治性多发性骨髓瘤患者的病情进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2639221346","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639221346?lang=zh_cn&edition=fundamental","pubTime":"2026-05-29 20:00","pubTimestamp":1780056051,"startTime":"0","endTime":"0","summary":"百时美施贵宝的药物可延缓难治性多发性骨髓瘤患者的病情进展Michael Erman路透5月29日 - 百时美施贵宝公司周五表示，在针对复发或对其他治疗无反应的多发性骨髓瘤患者的晚期临床试验中，其实验性口服药物梅齐多米德延缓了疾病进展。接受百时美施贵宝药物治疗的患者中位无进展生存期为18个月，而对照组仅为8.3个月。接受百时美施贵宝药物治疗的患者中，完全缓解率约为27%，是标准治疗组的三倍，完全缓解通常意味着无法检测到癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nL4S42612M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU1074936037.SGD","LU2125154935.USD","LU2242646821.SGD","LU1032466523.USD","LU0432979614.USD","LU1983299246.USD","IE0002141913.USD","LU0237698245.USD","LU2468319806.SGD","LU2125154778.USD","LU1571399168.USD","LU1868836914.USD","BMY","LU0267386448.USD","AMGN","IE00BJT1NW94.SGD","LU1670710588.SGD","LU1718418525.SGD","LU0096364046.USD","LU1868836591.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","LU0289739699.SGD","LU1261432733.SGD","LU2242652126.USD","LU0306807586.USD","LU0225284248.USD","LU1061106388.HKD","LU1323610961.USD","SG9999001440.SGD","IE00BSNM7G36.USD","LU1023059063.AUD","LU1093756168.USD","LU0058720904.USD","BK4581","BK4139","BK4566","LU1093756325.SGD","LU1868837136.USD","LU1868837300.USD","LU0122379950.USD","LU1291159041.SGD","LU0889565916.HKD","BK4559","LU0321505439.SGD","LU2133065610.SGD","LU0320765992.SGD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143833745","title":"施贵宝：Mezikd显著提升二/三线及高危疾病患者无进展生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=1143833745","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143833745?lang=zh_cn&edition=fundamental","pubTime":"2026-05-29 20:00","pubTimestamp":1780056024,"startTime":"0","endTime":"0","summary":"施贵宝公司公布的数据显示，其药物Mezikd在改善患者无进展生存期方面取得了显著成效。这一积极结果覆盖了两个关键的患者群体：接受过二线或三线治疗的患者，以及那些患有更高风险疾病的患者。\n研究结果表明，Mezikd疗法为这些通常预后更具挑战性的患者带来了新的希望。无进展生存期是衡量癌症治疗效果的关键指标，其显著改善意味着疾病进展被有效延缓。这对于临床治疗决策和患者长期管理具有重要指导意义。\n该数据的公布进一步巩固了Mezikd在相关治疗领域的潜力，也为施贵宝公司的产品管线增添了有力证据。后续进展值得市场与医学界持续关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4585","BMY","LU0225284248.USD","IE0009355771.USD","IE00BSNM7G36.USD","LU1571399168.USD","IE00B2B36J28.USD","LU1074936037.SGD","LU1670711040.USD","LU1868836914.USD","LU2125154778.USD","LU0882574055.USD","BK4532","LU1032466523.USD","LU1983299246.USD","IE00BFXG1179.USD","LU0306806265.USD","LU1093756325.SGD","LU1261432733.SGD","LU1585245621.USD","LU2360032135.SGD","IE00BJJMRZ35.SGD","LU0432979614.USD","LU1670711123.USD","LU0321505439.SGD","LU1868837136.USD","IE0002141913.USD","LU0096364046.USD","LU0267386448.USD","LU1868837300.USD","LU1670710588.SGD","LU1323610961.USD","LU2242652126.USD","LU1430594728.SGD","LU2242646821.SGD","LU1291159041.SGD","LU1989771016.USD","LU0237698245.USD","LU0225771236.USD","LU0456855351.SGD","LU1670710661.SGD","BK4588","BK4581","LU0306807586.USD","LU0321505868.SGD","BK4007","LU0061475181.USD","LU0985481810.HKD","LU1868836757.USD","LU1718418525.SGD","IE00BFTCPJ56.SGD","LU2125154935.USD","IE00BJT1NW94.SGD","LU0114720955.EUR","BK4559","LU1093756168.USD","LU1883839398.USD","LU1868836591.USD","LU0868494617.USD","LU2133065610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160502097","title":"施贵宝：Mezikd安全性特征与已知的Mezigdomide及联合疗法特征一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1160502097","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160502097?lang=zh_cn&edition=fundamental","pubTime":"2026-05-29 20:00","pubTimestamp":1780056024,"startTime":"0","endTime":"0","summary":"施贵宝公司公布的数据显示，其研究中的药物Mezikd的安全性特征，与已知的Mezigdomide及联合治疗方案的特征保持一致。这一发现为相关疗法的进一步开发提供了支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306806265.USD","LU0321505868.SGD","LU0882574055.USD","LU1868837300.USD","BMY","IE0002141913.USD","LU0456855351.SGD","LU1989771016.USD","LU0225771236.USD","IE00BJT1NW94.SGD","LU1323610961.USD","BK4581","LU1868837136.USD","LU2242652126.USD","IE00BFTCPJ56.SGD","LU1718418525.SGD","LU0432979614.USD","LU1983299246.USD","LU2125154935.USD","LU1261432733.SGD","LU1868836914.USD","LU1585245621.USD","LU0096364046.USD","BK4007","BK4559","LU0321505439.SGD","LU2242646821.SGD","BK4532","LU1074936037.SGD","LU1093756168.USD","IE00BJJMRZ35.SGD","LU0985481810.HKD","LU1670710588.SGD","IE0009355771.USD","LU1670711123.USD","LU1883839398.USD","LU0061475181.USD","LU1571399168.USD","BK4534","LU1093756325.SGD","BK4588","LU0868494617.USD","LU1430594728.SGD","LU1291159041.SGD","LU2133065610.SGD","LU0114720955.EUR","LU2360032135.SGD","LU0225284248.USD","LU1670710661.SGD","LU1032466523.USD","LU0306807586.USD","LU1868836591.USD","IE00BFXG1179.USD","IE00BSNM7G36.USD","LU0267386448.USD","LU0237698245.USD","LU2125154778.USD","LU1670711040.USD","IE00B2B36J28.USD","LU1868836757.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134916327","title":"施贵宝宣布：新药Celmod Mezigdomide在复发或难治性多发性骨髓瘤治疗中，较标准疗法降低疾病进展或死亡风险超50%","url":"https://stock-news.laohu8.com/highlight/detail?id=1134916327","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134916327?lang=zh_cn&edition=fundamental","pubTime":"2026-05-29 20:00","pubTimestamp":1780056024,"startTime":"0","endTime":"0","summary":"施贵宝公司公布了一项关键临床数据，其新型药物Celmod Mezigdomide在治疗复发或难治性多发性骨髓瘤患者时，展现出显著优势。与当前标准治疗方案相比，该药物能将患者疾病进展或死亡的风险降低超过50%。这一突破性结果为这一难治性血液肿瘤的治疗带来了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1261432733.SGD","LU1670711040.USD","LU2133065610.SGD","LU1585245621.USD","LU1323610961.USD","LU1868837300.USD","LU1983299246.USD","IE0009355771.USD","LU0432979614.USD","BK4559","LU0868494617.USD","LU0096364046.USD","BK4007","LU0237698245.USD","LU1093756325.SGD","LU1868836757.USD","LU0882574055.USD","LU1868836591.USD","LU0321505439.SGD","LU2242646821.SGD","LU1093756168.USD","LU2125154935.USD","IE00BSNM7G36.USD","LU1989771016.USD","BK4534","IE00BFTCPJ56.SGD","LU0225284248.USD","LU1430594728.SGD","LU1718418525.SGD","LU1291159041.SGD","LU0225771236.USD","LU1868836914.USD","IE00BJJMRZ35.SGD","LU0267386448.USD","LU2360032135.SGD","BK4532","BK4581","LU1868837136.USD","BMY","LU1670710588.SGD","IE0002141913.USD","LU0306806265.USD","LU1032466523.USD","LU1883839398.USD","LU0306807586.USD","LU2125154778.USD","LU1074936037.SGD","LU1670710661.SGD","LU1571399168.USD","LU1670711123.USD","LU2242652126.USD","LU0456855351.SGD","LU0321505868.SGD","BK4588","LU0061475181.USD","LU0114720955.EUR","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4585","IE00BFXG1179.USD","LU0985481810.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138660916","title":"施贵宝：Mezikd在复发或难治性多发性骨髓瘤中，较标准疗法降低疾病进展/死亡风险超50%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138660916","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138660916?lang=zh_cn&edition=fundamental","pubTime":"2026-05-29 20:00","pubTimestamp":1780056024,"startTime":"0","endTime":"0","summary":"施贵宝公司宣布，其药物Mezikd在治疗复发或难治性多发性骨髓瘤的临床试验中，取得了显著成果。数据显示，与现行标准疗法相比，Mezikd能够将患者的疾病进展或死亡风险降低超过50%。这一结果凸显了该药物在改善这类难治性血液癌症患者临床结局方面的巨大潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","LU1571399168.USD","LU0985481810.HKD","LU1585245621.USD","LU0456855351.SGD","LU0882574055.USD","LU0306806265.USD","LU1868836591.USD","LU0868494617.USD","LU1670711040.USD","LU0267386448.USD","LU1868836914.USD","LU1868837300.USD","LU1868837136.USD","LU0061475181.USD","LU0306807586.USD","BK4532","BK4534","LU1261432733.SGD","BK4585","LU1868836757.USD","LU1093756325.SGD","BK4581","LU1323610961.USD","LU2242652126.USD","LU2360032135.SGD","LU1883839398.USD","IE00B2B36J28.USD","LU0321505439.SGD","LU1093756168.USD","LU0237698245.USD","BMY","LU1074936037.SGD","LU2133065610.SGD","LU0225771236.USD","LU1989771016.USD","BK4559","IE00BJJMRZ35.SGD","LU1291159041.SGD","IE00BSNM7G36.USD","LU2242646821.SGD","LU0096364046.USD","IE0002141913.USD","LU1670710661.SGD","LU1430594728.SGD","LU2125154935.USD","LU1983299246.USD","LU1670711123.USD","LU2125154778.USD","IE00BFXG1179.USD","IE0009355771.USD","LU1670710588.SGD","LU1718418525.SGD","LU0321505868.SGD","LU0114720955.EUR","LU0432979614.USD","BK4588","BK4007","IE00BJT1NW94.SGD","LU1032466523.USD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132774432","title":"施贵宝：Mezikd展现更高总体缓解率及完全缓解或更佳疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1132774432","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132774432?lang=zh_cn&edition=fundamental","pubTime":"2026-05-29 20:00","pubTimestamp":1780056020,"startTime":"0","endTime":"0","summary":"施贵宝公布的数据显示，其药物Mezikd在临床试验中取得了更高的总体缓解率，并且观察到达到完全缓解或更佳疗效的患者比例有所提升。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","LU1670710661.SGD","LU0306806265.USD","LU1868836757.USD","LU1983299246.USD","LU2133065610.SGD","IE00BJJMRZ35.SGD","BK4559","BMY","LU0882574055.USD","LU1323610961.USD","LU0096364046.USD","BK4581","LU1032466523.USD","LU1868837136.USD","LU2360032135.SGD","LU1868836591.USD","BK4532","LU1989771016.USD","LU1883839398.USD","LU1670711123.USD","LU0267386448.USD","LU1261432733.SGD","LU0321505439.SGD","LU0321505868.SGD","LU1868837300.USD","IE0002141913.USD","IE0009355771.USD","LU1868836914.USD","LU2125154935.USD","LU0985481810.HKD","LU1093756168.USD","LU1585245621.USD","BK4007","IE00B2B36J28.USD","BK4534","IE00BFXG1179.USD","IE00BJT1NW94.SGD","LU0114720955.EUR","LU0868494617.USD","LU0456855351.SGD","LU0237698245.USD","LU1291159041.SGD","LU1670711040.USD","LU1718418525.SGD","BK4588","LU2242652126.USD","LU1093756325.SGD","LU2125154778.USD","LU0061475181.USD","LU0306807586.USD","LU1670710588.SGD","LU0432979614.USD","LU1430594728.SGD","BK4585","LU2242646821.SGD","LU0225771236.USD","LU1074936037.SGD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638511600","title":"JW首席执行官表示，中国制药行业未受北京方面对敏感技术交易审查的影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2638511600","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638511600?lang=zh_cn&edition=fundamental","pubTime":"2026-05-26 19:47","pubTimestamp":1779796050,"startTime":"0","endTime":"0","summary":"路透上海5月26日 - JW Therapeutics首席执行官周二表示，中国蓬勃发展的制药业并未受到北京方面对涉及敏感技术交易审查日趋严格的影响。随着专利到期临近，全球制药商正加紧  寻找中国研发的实验性药物以削减成本，行业分析师预测，今年生物技术许可交易将激增至历史新高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nL4S4230QI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2360032135.SGD","LU2242652126.USD","BK4559","LU1430594728.SGD","BK1161","LU0985481810.HKD","LU1718418525.SGD","LU1093756168.USD","LU1585245621.USD","BK4581","LU1291159041.SGD","BK4007","LU0114720955.EUR","LU0306807586.USD","LU0432979614.USD","BK1574","LU0882574055.USD","LU0225771236.USD","BK4534","LU1261432733.SGD","LU2133065610.SGD","BK4532","LU0321505868.SGD","IE00BFTCPJ56.SGD","LU1989771016.USD","LU0061475181.USD","LU1323610961.USD","BK1583","BMY","LU0237698245.USD","IE0009355771.USD","BK4585","IE00BSNM7G36.USD","LU1868837300.USD","02126","IE00BJJMRZ35.SGD","LU0321505439.SGD","IE00BJT1NW94.SGD","LU1093756325.SGD","LU1670711040.USD","LU0306806265.USD","IE00BFXG1179.USD","LU1032466523.USD","IE00B2B36J28.USD","LU0868494617.USD","LU1868836757.USD","LU1983299246.USD","LU2125154778.USD","LU1670710588.SGD","LU0267386448.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114324713","title":"施贵宝将于2026年ASCO®大会公布新数据，展示其肿瘤学产品组合与下一代管线的创新实力与广度","url":"https://stock-news.laohu8.com/highlight/detail?id=1114324713","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114324713?lang=zh_cn&edition=fundamental","pubTime":"2026-05-22 05:02","pubTimestamp":1779397351,"startTime":"0","endTime":"0","summary":"施贵宝公司宣布，将在2026年美国临床肿瘤学会（ASCO®）年会上公布一系列新的研究数据。这些数据将全面展示该公司在肿瘤学领域产品组合及下一代研发管线中科学创新的实力与广度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","IE00BFTCPJ56.SGD","LU0456855351.SGD","LU1983299246.USD","LU0868494617.USD","LU0306806265.USD","LU0321505868.SGD","LU0306807586.USD","LU1291159041.SGD","LU1670710661.SGD","LU0237698245.USD","LU2242646821.SGD","LU1032466523.USD","LU0225771236.USD","IE00BFXG1179.USD","IE00B2B36J28.USD","IE0002141913.USD","LU1868836757.USD","BK4559","LU2242652126.USD","LU0432979614.USD","LU1261432733.SGD","LU0985481810.HKD","IE0009355771.USD","LU1074936037.SGD","BK4007","LU1093756325.SGD","LU1718418525.SGD","LU2360032135.SGD","LU1883839398.USD","LU1868837300.USD","LU1989771016.USD","BMY","LU0114720955.EUR","LU1868837136.USD","LU2125154935.USD","LU2133065610.SGD","LU1571399168.USD","IE00BJT1NW94.SGD","LU2125154778.USD","LU1868836591.USD","LU1585245621.USD","BK4581","IE00BSNM7G36.USD","LU0321505439.SGD","LU0061475181.USD","LU0267386448.USD","LU0096364046.USD","LU1670711123.USD","LU0225284248.USD","LU1093756168.USD","BK4534","LU1868836914.USD","LU1670710588.SGD","BK4532","BK4585","IE00BJJMRZ35.SGD","LU0882574055.USD","LU1670711040.USD","LU1323610961.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636823676","title":"数据简报-制药行业加大力度布局人工智能，寄望于大幅削减成本并缩短研发周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2636823676","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636823676?lang=zh_cn&edition=fundamental","pubTime":"2026-05-20 22:14","pubTimestamp":1779286481,"startTime":"0","endTime":"0","summary":"数据简报-制药行业加大力度布局人工智能，寄望于大幅削减成本并缩短研发周期新增4月后公布的合作伙伴关系和交易。路透5月20日 - 制药公司正越来越多地借助人工智能来加速研发进程，押注于 新型建模工具和自动化实验室，以提升整个 研发管线的效率 。行业预测显示，利用机器学习优化靶点发现、分子设计及简化临床试验规划，有望在未来三到五年内将早期研发周期和成本减半。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nL4T41X1CT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANV","2NVD.UK","00179","MSFY","NVDU","MSFO","MSFT","AMZZ","MSFL","AZYY","AMZD","GGLS","MSFD","MSFX","TMO","MRK","NVDW","DIPS","NVDA","NVIW.SI","GOOGL","NVDS","LH","AMZY","SNVD.UK","RNAM","NVDX","NVDG","AMZW","MSFW","NVDQ","AZN.UK","AMZP","NVDL","KD","NVDB","GGLL","INCY","NVDO","AMZU","KVUE","MSFU","PFE","IQV","NVDY","BMY","3NVD.UK","USAW.SI","NVDD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636291840","title":"制药巨头集体拥抱AI智能体：百时美施贵宝(BMY.US)向3万员工推广Claude","url":"https://stock-news.laohu8.com/highlight/detail?id=2636291840","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636291840?lang=zh_cn&edition=fundamental","pubTime":"2026-05-20 21:05","pubTimestamp":1779282310,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百时美施贵宝正在向其3万多名员工推广Anthropic的旗舰级Claude AI平台，以此扩大人工智能和AI智能体在研究、临床开发及企业运营中的应用。此外，百时美施贵宝表示，它正在使用Anthropic的编程工具Claude Code来加速其软件和AI的开发。该公司还表示，目前正在评估将Claude AI智能体应用于研究、药物开发以及商业和医学事务等领域。Anthropic的竞争对手OpenAI也已与该行业的关键领头羊达成了合作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0225284248.USD","BK4588","LU1074936037.SGD","LU2125154935.USD","LU0225771236.USD","LU1093756325.SGD","LU2360032135.SGD","LU2242646821.SGD","BK4534","159819","LU2125154778.USD","LU1868837300.USD","LU1670711123.USD","IE00BFTCPJ56.SGD","IE00BFXG1179.USD","LU1868836914.USD","LU0432979614.USD","IE00BJT1NW94.SGD","BK4532","LU0061475181.USD","LU0306807586.USD","LU1868836591.USD","LU1868836757.USD","BK1191","LU0868494617.USD","LU0985481810.HKD","LU0114720955.EUR","LU1032466523.USD","LU1430594728.SGD","IE00B2B36J28.USD","LU0321505439.SGD","LU2133065610.SGD","LU1093756168.USD","01477","IE0002141913.USD","IE0009355771.USD","LU1670710661.SGD","LU2242652126.USD","LU1323610961.USD","BK1574","LU0267386448.USD","BK4585","LU0096364046.USD","LU1670710588.SGD","LU0321505868.SGD","LU1261432733.SGD","LU0237698245.USD","LU1983299246.USD","BMY","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":186,"code":"91000000","status":"200"}]}}